chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nasal congestion; Loss of appetite; Fever; Cold; Constipation; Cough; This spontaneous case was reported by a patient family member or friend and describes the occurrence of NASOPHARYNGITIS (Cold), NASAL CONGESTION (Nasal congestion), DECREASED APPETITE (Loss of appetite), CONSTIPATION (Constipation) and COUGH (Cough) in a 1-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Patient had no allergies to medications, food and other products. Patient never  had a COVID  test or diagnosis. Patient had no history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. Patient had no other vaccines given within 1 month prior to Moderna COVID-19 vaccine. .     On 29-Jun-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2022, the patient experienced COUGH (Cough). On 16-Jul-2022, the patient experienced CONSTIPATION (Constipation). On 22-Jul-2022, the patient experienced NASOPHARYNGITIS (Cold). On 23-Jul-2022, the patient experienced NASAL CONGESTION (Nasal congestion), DECREASED APPETITE (Loss of appetite) and PYREXIA (Fever). At the time of the report, NASOPHARYNGITIS (Cold) had not resolved and NASAL CONGESTION (Nasal congestion), DECREASED APPETITE (Loss of appetite), CONSTIPATION (Constipation), COUGH (Cough) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2022, SARS-CoV-2 test: (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The father called on behalf of his 1-year-old son. He had questioned about the COVID-19 vaccine. He wanted to know since his son currently has a cold which started on Friday 22Jul2022 would he be able to receive the vaccine on Wednesday 28Jul2022. Father stated patient had no immediate side effects after receiving the vaccine. The first  dose location was unknown. Father stated all his other vaccine has been given in the thigh. The expiration date for the first dose was not provided. Patient was taking drops of vitamin that goes into milk.HCP was aware of the side effects. No treatment medications were reported.
I waited 15minutes at the facility and then began walking home. Approximately 30minutes after receiving the injection, my throat started swelling a bit and the back of my tongue seemed to swell, too. It was very hard to swallow. I removed my Covid mask and continued to breathe normally. Approximately 40 minutes after receiving the injection, I took 2 Benadryl tablets. The throat swelling eased but it was still much more difficult to swallow than usual. About 4 hours after my first dose of Benadryl, I took 1 more tablet of Benadryl. I fell asleep and woke up feeling completely normal with normal swallowing. Note: at no time did I have a rash, I did not wheeze, and my blood pressure and heart rate seemed normal. I have no history of allergic reactions beyond possibly reacting to penicillin when I was age 2.
If you were talking about adverse events of the Pfizer vaccine for go series. There were none other than pain at the injection site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Jun2022 as dose 4 (booster), single (Lot number: FP7135) at the age of 66 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "hyper- cholesterolemia" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN, stop date: 05Aug2022; DILTIAZEM, start date: 03Aug2022. Vaccination history included: BNT162b2 (DOSE 3, SINGLE; Lot Number: 301458A, Anatomical location: Left arm), administration date: 29Sep2021, when the patient was 65-year-old, for Covid-19 Immunization; BNT162b2 (DOSE 2, SINGLE; Lot Number: EL9266, Anatomical location: Left arm), administration date: 25Feb2021, when the patient was 64-year-old, for Covid-19 Immunization; BNT162b2 (DOSE 1, SINGLE; Lot Number: EL9265, Anatomical location: Left arm), administration date: 28Jan2021, when the patient was 64-year-old, for Covid-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2022, outcome "unknown", described as "If you were talking about adverse events of the Pfizer vaccine for go series. There were none other than pain at the injection site".  Additional information: The patient had no known allergies. The patient received other medication in 2 weeks. It was reported that "If you were talking about adverse events of the Pfizer vaccine for go series", there were none other than pain at the injection site.
Had an issue with the lining of my heart; myocarditis; pericarditis; This is a spontaneous report received from a contactable consumer. This consumer (patient) reported for herself that:   A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE and second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. On an unspecified date, the patient experienced had an issue with the lining of my heart, myocarditis, pericarditis. Patient asked if she was eligible to take the booster or third shot. Went to pharmacist and had to fill out a form Number 14 says a history of myocarditis, inflammation of the heart, and pericarditis She got myocarditis and pericarditis three weeks ago after her first two COVID-19 shots. Her shots were fine. Is was said that she should not get the booster if she has pericarditis. Clarified her myocarditis and pericarditis have nothing to do with her COVID-19 vaccines. It happened at the Withheld. She was on a lot of blood thinners. Patient was on Colchicine and 3000mg of Aspirin (Intent: treatment). Therapeutic measures were taken as a result of had an issue with the lining of my heart, myocarditis, pericarditis. Events were considered as serious (medically significant). Patient received treatment with Colchicine and 3000mg of Aspirin. The clinical outcome of events were unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
death Narrative:  Patient received Moderna Covid vaccine #1 on 2/12/21. On 2/17/21, his son contacted the clinic social worker to inquire about home health services as he thought Patient had had a stroke (no longer able to walk and slurred speech). Patient refused to go to the hospital and son agreed to not have him admitted for fear that he would die alone in a hospital. Patient receives primary care from a provider and social worker suggested that he contact his PCP regarding home hospice services. No further notes of what occurred after that conversation and his date of death is reported as 3/21/21. No autopsy results available. 37 days from date vaccine to date of death.
pt c/o redness & swelling to lt upper & mid arm-beginning the evening p/vax;c/o severe pain & restricted movement of same limb;states had fever on 10/1/99 PM;called pvt MD on 10/1/99 & was seen by MD on 10/2/99 & tx w/pred & ATB;
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 26-JAN-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided). The vaccine had an excursion of 27 degrees Fahrenheit (-2.77 degrees Celsius) (lowest recorded temperature) for 636 hours (sum of hours in excursion). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
My left hand you can see the blue veins from the top of arm to my hands. 2 fingers had a red spot and in the middle of my knuckles and pinky finger had red spot. My left hand got so rough I can almost cut my face with my hand. I've been feeling tingly and crawling. I can't figure out what's going on.  It's still going on. It usually gets worse and worse. With headaches on the left side of my head. Breast swellingl on my 2nd reaction. They were swollen by the size of eggs.
Nausea; Full body muscle ache; Fever; Excessive tiredness; Dizziness; headache; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534) via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 44-year-old) at 17:30 as a single dose for COVID-19 immunisation. Medical history included HIV and obesity. The patient did not have any allergies to medications, food, or other products. Concomitant medications included ergocalciferol 50,000 (MANUFACTURER UNKNOWN), dolutegravir sodium (TIVICAY), emtricitabine, tenofovir alafenamide fumarate (DESCOVY) and fenofibrate (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested with COVID-19. On 30Mar2021 at 02:00, the patient experienced nausea, full body muscle aches, fever, excessive tiredness, dizziness and headache. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea, full body muscle aches, fever, excessive tiredness, dizziness and headache was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
had a bad reaction to her Flublok Vaccine; Initial information was received on 11-Dec-2020 regarding an unsolicited valid non-serious case from a other health professional.  This case involves an unknown age female patient who experienced had a bad reaction to her INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (vaccination complication).  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On 12-Oct-2020, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious had a bad reaction (vaccination complication) (unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  The reporter had a question, since this reaction was new to us, we want to know if you have ever seen this type of reaction? And also, is she covered for this year's flu season?  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the lot number for this case.
Patient described soreness at the site which radiated towards joint and at last severe pain that she can't move her arm up any more.
At approximately 1 hour after the vaccine, I started itching on the top of my feet. A few seconds later I started itching on my back and head followed by my legs. I became red in the areas that were itching but no hives. These were internal itching that wouldn't resolve with topical hydrocortisone cream which I tried immediately. They felt like they were under the skin and itching would not resolve.  I took 2 Benedryl  (Diphenhydramine HCl 25 mg x 2) and after about 45 minutes the itching resolved itself.  I have had this allergic reaction before to other medicines like beta-blockers, pain relievers & muscle relaxers. The following day I had mild itching so I took one Benedryl. I also had muscle aches all over and later the following day a migraine. The muscle aches and migraines resolved themselves the following day. I took Tylenol for migraine but that didn't touch it. The muscle aches and migraine I do not consider an adverse reaction ... it was to be expected according to the information I read.
This case was reported by a consumer via call center representative and described the occurrence of adverse reaction in a adult patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of adverse reaction (1st dose received on an unknown date, refer case US2019AMR056261). On an unknown date, the patient received the 2nd dose of SHINGRIX (subcutaneous). On an unknown date, unknown after receiving SHINGRIX, the patient experienced adverse reaction and intramuscular formulation administered by other route. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the adverse reaction and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the adverse reaction to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient received the SHINGRIX subcutaneously, which led to incorrect route of vaccine administration. The patient had experienced increased adverse reaction. No specific details were provided.
Bells Palsy Narrative:  5 days post vaccine Patient developed Bells Palsy, treated at ER, stroke r/o.
a low grade fever; feeling exhausted/feel regular tired; nausea/ slightly nauseous; arm pain/ arm is only sore now to the touch; This is a spontaneous report from a contactable consumer reported for a patient. A 36-year-old female patient (patient was not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiry date: unknown), via an unspecified route of administration, administered at an unspecified anatomical location on 26Jan2021 (age at vaccination was 36 years) as a 2ND DOSE, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiry date: unknown), via an unspecified route of administration, administered at an unspecified anatomical location on 05Jan2021 (age at vaccination was 36 years) as a 1ST DOSE, SINGLE for COVID-19 immunization. On 27Jan2021, the patient experienced nausea, arm pain and a low-grade fever. About 12 hours after feeling exhausted and slightly nauseous, fever was gone, arm was only sore now to the touch (almost better), just felt regular tired not exhausted. Nausea was gone. The facility where the most recent COVID-19 vaccine was administered was unknown. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown if the patient has been tested for COVID-19. It was unknown if the patient received treatment for the adverse events. The events were reported as non-serious. The outcome of the events was recovered in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Ataxia which developed the morning after vaccine administration.  Over the next 24 hours from the onset of ataxia the pt's symptoms dramatically improved to becoming symptom free.
HEADACHE, FATIGUE, 1/28 BODYACHE FATIGUE,  CHILLS NAUSEA RESOLVED 1530 ON 1/28/2021
3-5 hours after previous dose, Rx w Excedrin -- local injection pain, headache, chills, joint pain (elbows and back), muscle pain involving entire body, sweats, fatigue -- all resolved in 24 hours.  no loss of consciousness, no skin rash, no difficulty breathing
Red swelling around the injection area. Warm to touch. Got worse over 24 hour period.
Was given MMR on 8/12/2014 - then received Varicella on 8/19/2014. Parent notified that the child will need to repeat Varicella.
Cap removed without stopper being punctured; This case was reported by a nurse via call center representative and described the occurrence of wrong technique in product usage process in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced wrong technique in product usage process. On an unknown date, the outcome of the wrong technique in product usage process was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter reported a product storage error as the cap of Shingrix was removed without stopper being punctured. There was no temperature excursion. The cap was removed from the vials without the stopper being punctured with a needle, which led to wrong technique in product usage process. The vaccine was not administered. The reporter stated that, he/she was not allowed to share the patient's information and thought the report was a simple question but it had evolved to something more. The reporter did not consent to follow up.
Got super dizzy later last night; arms were bit sore; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL3248), via an unspecified route of administration in Jan2021 at single dose in arm for COVID-19 immunisation. Medical history was none. Concomitant medications included bupropion, buspirone, fexofenadine hydrochloride (ALLEGRA), ergocalciferol (VITAMIN D [ERGOCALCIFEROL]). The patient got the vaccine yesterday around noon and she was just looking at side effects and everything, one of them was listed under severe allergic reactions dizziness and she got super dizzy later last night (Jan2021), it's gone now. The patient wanted to know if that was something that she should go in for if it's okay because it went away. Patient stated because dizziness was listed under like a sign of a severe allergic reaction it didn't happen until probably about 8 hours after and it lasted a couple of hours, but now it's gone so she didn't know if that's something she needed go in for or not. The patient had taken some Advil just because her arms were bit sore (Jan2021) but other than, that was it. No Investigation Assessment. The outcome of the event "Got super dizzy later last night" was recovered in 2021, of "arms were bit sore" was unknown.
Lost smell and teste; Lost smell and teste; Congested; Coughing; Vomiting; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Lost smell and teste), AGEUSIA (Lost smell and teste), NASAL CONGESTION (Congested), COUGH (Coughing) and VOMITING (Vomiting) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANOSMIA (Lost smell and teste), AGEUSIA (Lost smell and teste), NASAL CONGESTION (Congested), COUGH (Coughing), VOMITING (Vomiting) and PYREXIA (Fever). At the time of the report, ANOSMIA (Lost smell and teste), AGEUSIA (Lost smell and teste), NASAL CONGESTION (Congested), COUGH (Coughing), VOMITING (Vomiting) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  Treatment information not provided.
PERSISTENT VOMITING.  HIVES BEGAN 8-10 HOURS LATER.  WAS ALSO ON AN ANTIBIOTIC WHICH WAS ALSO STOPPED.
Information has been received from a pharmacist via company representative referring to a patient of unknown age and gender. On an unknown date, a couple of months ago the patient was vaccinated with PNEUMOVAX 23 (route, dose, strength and lot were unknown). On an unknown date the patient experienced some pain that was not typical injection site pain. The patient also experienced some loss of mobility of an unspecified extremity, and that the patient consulted an unspecified healthcare provider. The unspecified healthcare provider told the patient that the loss of mobility was not related to the vaccine. The outcome of the events was unknown. The causality between some pain and the vaccine was not provided. Additional information has been requested.
Pt recvd 1st dose of Hep B vax on 13AUG90 w/no adverse rxn; On 13SEP90 recvd 2nd dose & on 1OCT90 pt exp malaise, urticaria, myalgia, weakness, abdominal discomfort, visual disturbances; 15JAN91 sx began to subside @ time of report;
This is former premature patient stable in room air and on full enteral feedings.  The infant was previously on Theophylline which was discontinued on 6-9-03 with the last reported level of 13.9.  The patient received immunizations on 6-10-03 at 145 pm.  On 6-11-03 at 0220 am, the infant had 5 episodes of bradycardia over a 1 1/2 hour period.  The infant does have a history of apnea/bradycardia and anemia of prematurity.  The patient received a blood transfusion on 6-9-03.  At 0220 am on 6-11-03 a CBC with diff/plts and a CXR was ordered.  A random theophylline level was also ordered.  The infant was then reloaded with theophylline.  The infant continued in RA with ocassional oxygen desaturations and an unlabored breathing.  On 6-16-03, another CBC with diff/plats was ordered and the infnat was restarted on synthroid which had been previouly discontinued on 6-1-03.  A urine sample was also sent with negative results noted.  On 6-18-03 the Theophylline was discontinued.